Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
1.840
+0.050 (2.79%)
At close: Jan 30, 2025, 4:00 PM
1.801
-0.039 (-2.10%)
After-hours: Jan 30, 2025, 7:04 PM EST
RVPH's stock price has decreased by -55.45% in the past year and price targets may not have had time to catch up.
RVPH Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$11.40
Upside
+519.57%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $11 | Strong Buy | Maintains | $14 → $11 | +497.83% | Jan 22, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +715.22% | Jan 21, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $7 | Hold → Strong Buy | Upgrades | $7 | +280.43% | Jan 10, 2025 |
| Roth MKM | Roth MKM | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +280.43% | Jan 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +715.22% | Nov 14, 2024 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +715.22% | Nov 13, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +715.22% | Sep 23, 2024 |
| Benchmark | Benchmark | Buy Reiterates $17 | Buy | Reiterates | $17 | +823.91% | Aug 26, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +660.87% | Jul 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +660.87% | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $14 | Strong Buy | Maintains | $20 → $14 | +660.87% | Jun 11, 2024 |
| Benchmark | Benchmark | Buy Reiterates $17 | Buy | Reiterates | $17 | +823.91% | May 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +986.96% | Apr 22, 2024 |
| Benchmark | Benchmark | Buy Reiterates $17 | Buy | Reiterates | $17 | +823.91% | Apr 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +986.96% | Mar 25, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.